Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As J&J Backs Away From The Altar, Guidant Asks Court For Shotgun Wedding

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson is likely to point to Guidant's weak third quarter sales and earnings as evidence that recent recalls have had a "material adverse effect" on Guidant

You may also be interested in...



Boston Scientific Offers $25 Bil. To Nab Guidant From J&J

Convinced that Johnson & Johnson is undervaluing Guidant, Boston Scientific made an offer of $25 bil. for the cardiovascular device firm on Dec. 5 - approximately $3 bil. more than J&J has agreed to pay

Boston Scientific Offers $25 Bil. To Nab Guidant From J&J

Convinced that Johnson & Johnson is undervaluing Guidant, Boston Scientific made an offer of $25 bil. for the cardiovascular device firm on Dec. 5 - approximately $3 bil. more than J&J has agreed to pay

Guidant Files Lawsuit To Force J&J To Complete Acquisition

Guidant filed a civil lawsuit against Johnson & Johnson on Nov. 7 in an effort to force the healthcare giant to complete its proposed $25.4 bil. acquisition

Related Content

UsernamePublicRestriction

Register

MT022884

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel